Your session is about to expire
← Back to Search
Botulinum Toxin for Androgenic Alopecia
Study Summary
This trial will test whether botulinum toxin can help treat pattern hair loss.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2020 Phase 2 trial • 21 Patients • NCT02107261Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had reactions to certain medications before.I haven't taken any treatments for hair loss in the last 6 months.I do not have skin or body-wide diseases that could affect my treatment.I have signs of infection where I was injected.I agree to use birth control during the study.I currently have a cold or sinus infection.I have been diagnosed with mild to moderate hair loss.I am not taking any medications that could affect the study.I am between 22-55 years old with mild to moderate hair loss and no health issues affecting study participation.I have mild to moderate hair loss as assessed by a doctor.
- Group 1: Single treatment with Xeomin® (incobotulinumtoxin A)
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has incobotulinumtoxin A attained regulatory acceptance by the FDA?
"Based on our risk assessment, incobotulinumtoxin A received a score of 2 due to limited evidence regarding its efficacy but some data demonstrating safety."
Are there any vacancies for potential participants in this clinical trial?
"Affirmative. According to information on clinicaltrials.gov, this medical research is currently looking for volunteers. First posted on August 12th 2022, the trial was updated as recently as October 3rd of the same year and requires 20 individuals from 2 sites in total."
How many persons are being included in the current clinical trial?
"Affirmative. According to the information available on clinicaltrials.gov, this particular medical study posted on August 12th 2022 is still seeking participants. A total of 20 people are required from two distinct facilities for the trial's completion."
Is the elderly population eligible for this investigation?
"Based on the requirements for participation, eligible individuals must be between 22 and 45 years old."
What types of individuals are most suitable for this research?
"This clinical trial seeks to enrol 20 individuals aged between 22 and 45 with mild to moderate androgenetic alopecia. Furthermore, sexually active females of childbearing age must agree to use a medically-approved contraceptive while receiving study product. In addition, subjects are required sign an informed consent document, photo release form, confirm their diagnosis as agreed by the investigator, maintain the same hair grooming and style routine during the duration of the study (or remain sexually inactive if not practicing contraception)."
Who else is applying?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What site did they apply to?
Why did patients apply to this trial?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger